Michael D. Hooven is Director at AtriCure, Inc. (ATRC). They have made 11 open-market trades across 1 company since 2008, most recently 2017-05-05.
CIK 0001336090
7 open-market purchases totalling $149K since 2008, against 4 sales. Across 7 scored buys the stock is down 4.1% at ninety days, and 4.3 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ATRC | 57,049 | $3.7M |
Shares reported on the most recent Form 4, priced at the 2017-05-09 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -16.7% | -4.1% | -4.1% |
| Alpha | -10.9% | -4.3% | -4.3% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATRC | SELL | 2017-05-05 | 2017-05-09 | $22.08 | $442K | -2.9% | -3.0% | +3.3% |
| ATRC | SELL · 10b5-1 | 2015-03-30 | 2015-04-01 | $20.81 | $1.5M | -16.7% | -4.1% | -4.1% |
| ATRC | SELL · 10b5-1 | 2014-12-31 | 2015-01-02 | $20.00 | $577K | -16.7% | -4.1% | -4.1% |
| ATRC | BUY | 2012-09-14 | 2012-09-17 | $7.69 | $8K | -16.7% | -4.1% | -4.1% |
| ATRC | BUY | 2012-09-13 | 2012-09-14 | $7.37 | $8K | -16.7% | -4.1% | -4.1% |
| ATRC | BUY | 2012-09-12 | 2012-09-13 | $7.10 | $8K | -16.7% | -4.1% | -4.1% |
| ATRC | BUY | 2012-09-11 | 2012-09-12 | $7.18 | $8K | -16.7% | -4.1% | -4.1% |
| ATRC | BUY | 2012-09-10 | 2012-09-11 | $7.15 | $9K | -16.7% | -4.1% | -4.1% |
| ATRC | BUY | 2012-09-07 | 2012-09-07 | $6.88 | $8K | -16.7% | -4.1% | -4.1% |
| ATRC | SELL | 2012-03-13 | 2017-02-23 | $10.02 | $35K | +4.0% | +10.7% | +25.0% |
| ATRC | SELL | 2011-06-13 | 2011-06-14 | $14.00 | $420K | -16.7% | -4.1% | -4.1% |
| ATRC | SELL | 2010-11-10 | 2010-11-12 | $8.10 | $135K | -16.7% | -4.1% | -4.1% |
| ATRC | BUY | 2008-06-09 | 2008-06-10 | $10.36 | $99K | -16.7% | -4.1% | -4.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.